A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Zampilimab in Adult Kidney Transplant Recipients With Chronic Allograft Injury
Clinical trial NCT04335578 · TERMINATED
Trial details
- NCT number
- NCT04335578
- Sponsor
- UCB Biopharma SRL
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-21
- Primary completion
- 2022-05-04
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.